CD4 and COVID-19: Pathological findings had revealed that counts of peripheral CD4+ T and CD8+ T cells were substantially decreased in COVID-19 patients with ARDS [28], suggesting that SARS-CoV-2 may exert major impact on lymphocytes, especially T lymphocytes.